Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Osteoporosis

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 72 articles:
HTML format
Text format



Single Articles


    May 2019
  1. MAI HT, Tran TS, Ho-Le TP, Center JR, et al
    Response to Letter to the Editor: Two-thirds of all fractures are not attributable to osteoporosis and advancing age: implication for fracture prevention.
    J Clin Endocrinol Metab. 2019 May 22. pii: 5492494. doi: 10.1210/jc.2019-01016.
    PubMed     Text format    


  2. KHOSRAVI A, Mansournia MA
    Letter to the Editor: Two-thirds of all fractures are not attributable to osteoporosis and advancing age: implication for fracture prevention.
    J Clin Endocrinol Metab. 2019 May 22. pii: 5492491. doi: 10.1210/jc.2019-00935.
    PubMed     Text format    


  3. SUGIYAMA T
    Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline".
    J Clin Endocrinol Metab. 2019 May 16. pii: 5489446. doi: 10.1210/jc.2019-01017.
    PubMed     Text format    


  4. BARRIONUEVO P, Gionfriddo MR, Castaneda-Guarderas A, Zeballos-Palacios C, et al
    Women's Values and Preferences Regarding Osteoporosis Treatments: A Systematic Review.
    J Clin Endocrinol Metab. 2019;104:1631-1636.
    PubMed     Text format     Abstract available


  5. EASTELL R, Rosen CJ, Black DM, Cheung AM, et al
    Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2019;104:1595-1622.
    PubMed     Text format     Abstract available


    April 2019
  6. EASTELL R, Rosen CJ
    Response to Letter to the Editor: Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.
    J Clin Endocrinol Metab. 2019 Apr 18. pii: 5473527. doi: 10.1210/jc.2019-00777.
    PubMed     Text format    


  7. RODRIGUEZ EG, Lamy O
    Letter to the Editor "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline."
    J Clin Endocrinol Metab. 2019 Apr 18. pii: 5473525. doi: 10.1210/jc.2019-00747.
    PubMed     Text format    


  8. PAZIANAS M
    Letter to the Editor: Dietary calcium intake and bone loss over 6 years in osteopenic postmenopausal women.
    J Clin Endocrinol Metab. 2019 Apr 16. pii: 5450711. doi: 10.1210/jc.2019-00785.
    PubMed     Text format    


  9. WON SH, Kim JH
    Letter to the Editor: Evidence of a causal effect of estradiol on fracture risk in men.
    J Clin Endocrinol Metab. 2019 Apr 16. pii: 5450710. doi: 10.1210/jc.2019-00736.
    PubMed     Text format    


  10. MAI HT, Tran TS, Ho-Le TP, Center JR, et al
    Two-thirds of all fractures are not attributable to osteoporosis and advancing age: implication for fracture prevention.
    J Clin Endocrinol Metab. 2019 Apr 5. pii: 5427152. doi: 10.1210/jc.2018-02614.
    PubMed     Text format     Abstract available


    March 2019
  11. REID LJ, Muthukrishnan B, Patel D, Seckl JR, et al
    Predictors of nephrolithiasis, osteoporosis and mortality in primary hyperparathyroidism.
    J Clin Endocrinol Metab. 2019 Mar 27. pii: 5419224. doi: 10.1210/jc.2018-02483.
    PubMed     Text format     Abstract available


  12. BRISTOW SM, Horne AM, Gamble GD, Mihov B, et al
    Dietary calcium intake and bone loss over 6 years in osteopenic postmenopausal women.
    J Clin Endocrinol Metab. 2019 Mar 21. pii: 5393287. doi: 10.1210/jc.2019-00111.
    PubMed     Text format     Abstract available


    February 2019
  13. NAPOLI N, Conte C, Pedone C, Strotmeyer ES, et al
    Effect of Insulin Resistance on BMD and Fracture Risk in Older Adults.
    J Clin Endocrinol Metab. 2019 Feb 25. pii: 5364431. doi: 10.1210/jc.2018-02539.
    PubMed     Text format     Abstract available


  14. WATTS NB, Grbic JT, Binkley N, Papapoulos S, et al
    Invasive Oral Procedures and Events in Women With Postmenopausal Osteoporosis Treated With Denosumab for up to 10 Years.
    J Clin Endocrinol Metab. 2019 Feb 13. pii: 5316168. doi: 10.1210/jc.2018-01965.
    PubMed     Text format     Abstract available


    January 2019
  15. CAULEY JA, Ruppert K, Lian Y, Finkelstein JS, et al
    Serum Sex Hormones and the Risk of Fracture across the Menopausal Transition: Study of Women's Health Across the Nation.
    J Clin Endocrinol Metab. 2019 Jan 23. pii: 5298592. doi: 10.1210/jc.2018-02047.
    PubMed     Text format     Abstract available


  16. VAVANIKUNNEL J, Charlier S, Becker C, Schneider C, et al
    Association between glycemic control and risk of fracture in diabetic patients: A nested case-control study.
    J Clin Endocrinol Metab. 2019 Jan 16. pii: 5244186. doi: 10.1210/jc.2018-01879.
    PubMed     Text format     Abstract available


    December 2018
  17. LYU H, Jundi B, Xu C, Tedeschi SK, et al
    Comparison of denosumab vs. bisphosphonates in osteoporosis patients: A meta-analysis of randomized controlled trials.
    J Clin Endocrinol Metab. 2018 Dec 10. pii: 5235617. doi: 10.1210/jc.2018-02236.
    PubMed     Text format     Abstract available


    September 2018
  18. KINDLER JM, Lappe JM, Gilsanz V, Oberfield S, et al
    Lumbar Spine Bone Mineral Apparent Density in Children: Results from the Bone Mineral Density in Childhood Study.
    J Clin Endocrinol Metab. 2018 Sep 27. pii: 5107297. doi: 10.1210/jc.2018-01693.
    PubMed     Text format     Abstract available


  19. TOURNIS S, Trovas G, Triantafyllopoulos IK, Balanika AP, et al
    Letter to the editor. Evaluation of bone mineral density using DXA and central QCT in postmenopausal patients under thyrotropin suppressive therapy.
    J Clin Endocrinol Metab. 2018 Sep 26. pii: 5106939. doi: 10.1210/jc.2018-01638.
    PubMed     Text format    


  20. JEON YK, Kim IJ, Kim K
    Reply to a Letter to the Editor: "Evaluation of bone mineral density using DXA and central QCT in postmenopausal patients under thyrotropin suppressive therapy".
    J Clin Endocrinol Metab. 2018 Sep 26. pii: 5106936. doi: 10.1210/jc.2018-02004.
    PubMed     Text format    


  21. MA J, Siminoski K, Alos N, Halton J, et al
    Impact of vertebral fractures and glucocorticoid exposure on height deficits in children during treatment for leukemia.
    J Clin Endocrinol Metab. 2018 Sep 20. pii: 5103424. doi: 10.1210/jc.2018-01083.
    PubMed     Text format     Abstract available


  22. NETHANDER M, Vandenput L, Eriksson AL, Windahl S, et al
    Evidence of a Causal Effect of Estradiol on Fracture Risk in Men.
    J Clin Endocrinol Metab. 2018 Sep 11. pii: 5094017. doi: 10.1210/jc.2018-00934.
    PubMed     Text format     Abstract available


    July 2018
  23. HAMILTON EJ, Drinkwater JJ, Chubb SAP, Rakic V, et al
    A ten-year prospective study of bone mineral density and bone turnover in males and females with type 1 diabetes.
    J Clin Endocrinol Metab. 2018 Jul 18. pii: 5055538. doi: 10.1210/jc.2018-00850.
    PubMed     Text format     Abstract available


  24. LIN SM, Wang JH, Liang CC, Huang HK, et al
    Statin use is associated with decreased osteoporosis and fracture risks in stroke patients.
    J Clin Endocrinol Metab. 2018 Jul 2. pii: 5047290. doi: 10.1210/jc.2018-00652.
    PubMed     Text format     Abstract available


  25. SHEN J, Griffith JF, Zhu TY, Tang P, et al
    Bone Mass, Microstucture And Strength Can Discriminate Vertebral Fracture In Patients on Long-Term Steroid Treatment.
    J Clin Endocrinol Metab. 2018 Jul 2. pii: 5047293. doi: 10.1210/jc.2018-00490.
    PubMed     Text format     Abstract available


    June 2018
  26. KIM K, Kim IJ, Pak K, Kim SJ, et al
    Evaluation of bone mineral density using DXA and central QCT in postmenopausal patients under thyrotropin suppressive therapy.
    J Clin Endocrinol Metab. 2018 Jun 21. pii: 5041930. doi: 10.1210/jc.2017-02704.
    PubMed     Text format     Abstract available


  27. LEWIECKI EM, Blicharski T, Goemaere S, Lippuner K, et al
    A Phase 3 Randomized Placebo-controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis.
    J Clin Endocrinol Metab. 2018 Jun 20. pii: 5040365. doi: 10.1210/jc.2017-02163.
    PubMed     Text format     Abstract available


    May 2018
  28. KIM SY, Kong IG, Lim H, Choi HG, et al
    Increased risk of sudden sensory neural hearing loss in osteoporosis: A longitudinal follow up study.
    J Clin Endocrinol Metab. 2018 May 28. pii: 5005943. doi: 10.1210/jc.2018-00717.
    PubMed     Text format     Abstract available


  29. BONE HG, Cosman F, Miller PD, Williams GC, et al
    ACTIVExtend: 24 Months of Alendronate after 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis.
    J Clin Endocrinol Metab. 2018 May 24. pii: 5001732. doi: 10.1210/jc.2018-00163.
    PubMed     Text format     Abstract available


  30. SUGIYAMA T
    Letter to the Editor: Effects of long-term denosumab on bone histomorphometry and mineralization in women with postmenopausal osteoporosis.
    J Clin Endocrinol Metab. 2018 May 15. pii: 4995803. doi: 10.1210/jc.2018-00886.
    PubMed     Text format    


    April 2018
  31. DEMPSTER DW, Brown JP, Fahrleitner-Pammer A, Kendler D, et al
    Effects of Long-term Denosumab on Bone Histomorphometry and Mineralization in Women With Postmenopausal Osteoporosis.
    J Clin Endocrinol Metab. 2018 Apr 16. pii: 4970149. doi: 10.1210/jc.2017-02669.
    PubMed     Text format     Abstract available


    March 2018
  32. LIU L, Wen Y, Zhang L, Xu P, et al
    Assessing the associations of blood metabolites with osteoporosis: a Mendelian randomization study.
    J Clin Endocrinol Metab. 2018 Mar 1. pii: 4916908. doi: 10.1210/jc.2017-01719.
    PubMed     Text format     Abstract available


  33. MAKITIE RE, Hackl M, Niinimaki R, Kakko S, et al
    Altered MicroRNA Profile in Osteoporosis Caused by Impaired WNT Signaling.
    J Clin Endocrinol Metab. 2018 Mar 1. pii: 4916912. doi: 10.1210/jc.2017-02585.
    PubMed     Text format     Abstract available


    February 2018
  34. KHOSLA S, Farr JN, Kirkland JL
    Inhibiting Cellular Senescence: A New Therapeutic Paradigm for Age-Related Osteoporosis.
    J Clin Endocrinol Metab. 2018 Feb 7. pii: 4841935. doi: 10.1210/jc.2017-02694.
    PubMed     Text format     Abstract available


  35. KIM BJ, Kwak MK, Ahn SH, Kim H, et al
    Lower Trabecular Bone Score in Patients With Primary Aldosteronism: Human Skeletal Deterioration by Aldosterone Excess.
    J Clin Endocrinol Metab. 2018;103:615-621.
    PubMed     Text format     Abstract available


    January 2018

  36. CORRIGENDUM FOR "Identification of Novel Potentially Pleiotropic Variants Associated With Osteoporosis and Obesity Using the cFDR Method".
    J Clin Endocrinol Metab. 2018 Jan 22. pii: 4819317. doi: 10.1210/jc.2018-00141.
    PubMed     Text format    


  37. GOSSIEL F, Scott JR, Paggiosi MA, Naylor KE, et al
    The effect of teriparatide treatment on circulating periostin and its relationship to regulators of bone formation and BMD in postmenopausal women with osteoporosis.
    J Clin Endocrinol Metab. 2018 Jan 22. pii: 4819314. doi: 10.1210/jc.2017-00283.
    PubMed     Text format     Abstract available


  38. BERGMAN J, Nordstrom A, Nordstrom P
    Alendronate Use and the Risk of Nonvertebral Fracture During Glucocorticoid Therapy: A Retrospective Cohort Study.
    J Clin Endocrinol Metab. 2018;103:306-313.
    PubMed     Text format     Abstract available


    December 2017
  39. SOUCEK O, Schonau E, Lebl J, Willnecker J, et al
    A 6-Year Follow-Up of Fracture Incidence and Volumetric Bone Mineral Density Development in Girls with Turner Syndrome.
    J Clin Endocrinol Metab. 2017 Dec 28. pii: 4780815. doi: 10.1210/jc.2017-02381.
    PubMed     Text format     Abstract available


  40. ANASTASILAKIS AD, Makras P, Pikilidou M, Tournis S, et al
    Changes of circulating micro-RNAs in response to treatment with teriparatide or denosumab in postmenopausal osteoporosis.
    J Clin Endocrinol Metab. 2017 Dec 22. pii: 4772360. doi: 10.1210/jc.2017-02406.
    PubMed     Text format     Abstract available


    November 2017
  41. HU Y, Tan LJ, Chen XD, Liu Z, et al
    Identification of Novel Potentially-pleiotropic Variants Associated With Osteoporosis and Obesity Using cFDR method.
    J Clin Endocrinol Metab. 2017 Nov 14. doi: 10.1210/jc.2017-01531.
    PubMed     Text format     Abstract available


  42. MAZZIOTTI G, Formenti AM, Frara S, Olivetti R, et al
    HIGH PREVALENCE OF RADIOLOGICAL VERTEBRAL FRACTURES IN WOMEN ON TSH-SUPPRESSIVE THERAPY FOR THYROID CARCINOMA.
    J Clin Endocrinol Metab. 2017 Nov 7. doi: 10.1210/jc.2017-01986.
    PubMed     Text format     Abstract available


  43. LEE RH, Sloane R, Pieper C, Lyles KW, et al
    Clinical fractures among older men with diabetes are mediated by diabetic complications.
    J Clin Endocrinol Metab. 2017 Nov 1. doi: 10.1210/jc.2017-01593.
    PubMed     Text format     Abstract available


  44. SINGH-OSPINA N, Maraka S, Rodriguez-Gutierrez R, Davidge-Pitts C, et al
    Effect of Sex Steroids on the Bone Health of Transgender Individuals: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2017;102:3904-3913.
    PubMed     Text format     Abstract available


    September 2017
  45. SAKKA S, Gafni RI, Davies JH, Clarke B, et al
    Bone structural characteristics and response to bisphosphonate treatment in children with Hajdu-Cheney Syndrome.
    J Clin Endocrinol Metab. 2017 Sep 8. doi: 10.1210/jc.2017-01102.
    PubMed     Text format     Abstract available


  46. SMEETS CCJ, van der Steen M, Renes JS, Hokken-Koelega ACS, et al
    Bone Mineral Density After Cessation of GH Treatment in Young Adults Born SGA: A 5-Year Longitudinal Study.
    J Clin Endocrinol Metab. 2017;102:3508-3516.
    PubMed     Text format     Abstract available


    July 2017
  47. SWANSON C, Shea SA, Wolfe P, Cain SW, et al
    Bone Turnover Markers After Sleep Restriction and Circadian Disruption: A Mechanism for Sleep-Related Bone Loss in Humans.
    J Clin Endocrinol Metab. 2017 Jul 26. doi: 10.1210/jc.2017-01147.
    PubMed     Text format     Abstract available


  48. BALASURIYA CND, Evensen KAI, Mosti MP, Brubakk AM, et al
    Peak Bone Mass and Bone Microarchitecture in Adults Born With Low Birth Weight Preterm or at Term: A Cohort Study.
    J Clin Endocrinol Metab. 2017;102:2491-2500.
    PubMed     Text format     Abstract available


    June 2017
  49. PASCHOU S, Dede AD, Anagnostis PG, Vryonidou A, et al
    Type 2 diabetes and osteoporosis: a guide to optimal management.
    J Clin Endocrinol Metab. 2017 Jun 21. doi: 10.1210/jc.2017-00042.
    PubMed     Text format     Abstract available


  50. LAMY O, Gonzalez-Rodriguez E, Aubry-Rozier B
    Response to Letter: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.
    J Clin Endocrinol Metab. 2017;102:2112.
    PubMed     Text format    


  51. RAO SD, Qiu S, Dhaliwal R, Bhadada SK, et al
    Letter to the Editor: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation.
    J Clin Endocrinol Metab. 2017;102:2111.
    PubMed     Text format    


    May 2017
  52. VERROKEN C, Pieters W, Beddeleem L, Goemaere S, et al
    CORTICAL BONE SIZE DEFICIT IN ADULT PATIENTS WITH TYPE 1 DIABETES MELLITUS.
    J Clin Endocrinol Metab. 2017 May 22. doi: 10.1210/jc.2017-00620.
    PubMed     Text format     Abstract available


  53. SCHORR M, Marengi DA, Pulumo R, Yu E, et al
    Oxytocin and its relationship to body composition, bone mineral density and hip geometry across the weight spectrum
    J Clin Endocrinol Metab. 2017 May 10. doi: 10.1210/jc.2016-3963.
    PubMed     Text format     Abstract available


  54. OHLSSON C, Sundh D, Wallerek A, Nilsson M, et al
    Response to Letter: "Cortical Bone Area Predicts Incident Fractures Independently of Areal Bone Mineral Density in Older Men".
    J Clin Endocrinol Metab. 2017;102:1782.
    PubMed     Text format    


  55. ZHANG Y, Xiao H, Sheng ZF
    Letter to the Editor: "Cortical Bone Area Predicts Incident Fractures Independently of Areal Bone Mineral Density in Older Men".
    J Clin Endocrinol Metab. 2017;102:1780-1781.
    PubMed     Text format    


    April 2017
  56. GONZALEZ RODRIGUEZ E, Lamy O, Stoll D, Metzger M, et al
    High evening cortisol level is associated with low TBS and increased prevalent vertebral fractures. OsteoLaus study.
    J Clin Endocrinol Metab. 2017 Apr 4. doi: 10.1210/jc.2016-3804.
    PubMed     Text format     Abstract available


  57. WESSELING-PERRY K, Makitie RE, Valimaki VV, Laine T, et al
    Osteocyte protein expression is altered in low-turnover osteoporosis caused by mutations in WNT1 and PLS3.
    J Clin Endocrinol Metab. 2017 Apr 3. doi: 10.1210/jc.2017-00099.
    PubMed     Text format     Abstract available


    March 2017
  58. CHEMAITILLY W, Li Z, Krasin MJ, Brooke RJ, et al
    Premature Ovarian Insufficiency in Childhood Cancer Survivors: A Report from the St. Jude Lifetime Cohort.
    J Clin Endocrinol Metab. 2017 Mar 24. doi: 10.1210/jc.2016-3723.
    PubMed     Text format     Abstract available


  59. VALDERRABANO RJ, Lee J, Lui LY, Hoffman AR, et al
    Older Men with Anemia Have Increased Fracture Risk Independent of Bone Mineral Density.
    J Clin Endocrinol Metab. 2017 Mar 20. doi: 10.1210/jc.2017-00266.
    PubMed     Text format     Abstract available


  60. WANG Y, Wactawski-Wende J, Sucheston-Campbell LE, Preus L, et al
    Gene-hormone therapy interaction and fracture risk in postmenopausal women.
    J Clin Endocrinol Metab. 2017 Mar 6. doi: 10.1210/jc.2016-2936.
    PubMed     Text format     Abstract available


  61. BURR DB, Lane JE, Howe TS, Ng AC, et al
    Response to PD Miller, Underdiagnosis and Undertreatment of Osteoporosis: The Battle To Be Won.
    J Clin Endocrinol Metab. 2017;102:1088-1089.
    PubMed     Text format    


  62. TROVAS G
    Letter to the Editor: Severe Rebound-Associated Vertebral Fractures After Denosumab Discontinuation: Nine Clinical Cases Report.
    J Clin Endocrinol Metab. 2017;102:1086.
    PubMed     Text format    


    February 2017
  63. NOTSU M, Yamauchi M, Yamamoto M, Nawata K, et al
    Primary aldosteronism as a risk factor for vertebral fracture.
    J Clin Endocrinol Metab. 2017 Feb 9. doi: 10.1210/jc.2016-3206.
    PubMed     Text format    


    January 2017
  64. VUORIMIES I, Mayranpaa MK, Valta H, Kroger H, et al
    Bisphosphonate Treatment and the Characteristics of Femoral Fractures in Children with Osteogenesis Imperfecta.
    J Clin Endocrinol Metab. 2017 Jan 17. doi: 10.1210/jc.2016-3745.
    PubMed     Text format     Abstract available


  65. WATTS NB, Cauley JA, Jackson RD, LaCroix AZ, et al
    No Increase in Fractures After Stopping Hormone Therapy: Results From the Women's Health Initiative.
    J Clin Endocrinol Metab. 2017;102:302-308.
    PubMed     Text format     Abstract available


    November 2016
  66. OHLSSON C, Sundh D, Wallerek A, Nilsson M, et al
    Cortical bone area predicts incident fractures independently of areal bone mineral density in older men.
    J Clin Endocrinol Metab. 2016 Nov 22:jc20163177.
    PubMed     Text format     Abstract available


  67. PAPADAKIS G, Hans D, Gonzalez-Rodriguez E, Vollenweider P, et al
    The Benefit of Menopausal Hormone Therapy on Bone Density and Microarchitecture Persists After its Withdrawal.
    J Clin Endocrinol Metab. 2016 Nov 17:jc20162695.
    PubMed     Text format     Abstract available


  68. CHAWLA H, Saha S, Kandaswamy D, Sharma R, et al
    Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long term follow-up.
    J Clin Endocrinol Metab. 2016 Nov 4:jc20163292.
    PubMed     Text format     Abstract available


    October 2016
  69. VALIMAKI VV, Makitie O, Pereira R, Laine C, et al
    Teriparatide Treatment in Patients with WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis - A Pilot Study.
    J Clin Endocrinol Metab. 2016 Oct 12:jc20162423.
    PubMed     Text format     Abstract available


  70. LAMY O, Gonzalez-Rodriguez E, Stoll D, Hans D, et al
    Severe rebound-associated vertebral fractures after denosumab discontinuation: nine clinical cases report.
    J Clin Endocrinol Metab. 2016 Oct 12:jc20163170.
    PubMed     Text format     Abstract available


    September 2016
  71. ESCHE J, Johner S, Shi L, Schonau E, et al
    Urinary citrate, an index of acid-base status, predicts bone strength in youths and fracture risk in adult females.
    J Clin Endocrinol Metab. 2016 Sep 27:jc20162677.
    PubMed     Text format     Abstract available


    May 2016
  72. SHANBHOGUE VV, Finkelstein JS, Bouxsein ML, Yu EW, et al
    Association between insulin resistance and bone structure in non-diabetic postmenopausal women.
    J Clin Endocrinol Metab. 2016 May 31:jc20161726.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: